{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:37:23Z","timestamp":1769632643392,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072079"],"award-info":[{"award-number":["82072079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.neulet.2022.136546","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T03:33:26Z","timestamp":1645500806000},"page":"136546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Low high-density lipoprotein cholesterol and apolipoprotein A-I levels are associated with poor outcome and relapse in autoimmune encephalitis"],"prefix":"10.1016","volume":"775","author":[{"given":"Fei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shougang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neulet.2022.136546_b0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/WCO.0000000000000087","article-title":"Autoimmune encephalitis as differential diagnosis of infectious encephalitis","volume":"27","author":"Armangue","year":"2014","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2022.136546_b0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.neulet.2022.136546_b0015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/dmcn.13448","article-title":"Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases","volume":"59","author":"Nosadini","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.neulet.2022.136546_b0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0000000000001190","article-title":"The spectrum of acute encephalitis: causes, management, and predictors of outcome","volume":"84","author":"Singh","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neulet.2022.136546_b0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ane.12723","article-title":"Risk factors for mortality in patients with anti-NMDA receptor encephalitis","volume":"136","author":"Chi","year":"2017","journal-title":"Acta Neurol. Scand."},{"issue":"9","key":"10.1016\/j.neulet.2022.136546_b0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.0b013e3182a2cc6d","article-title":"Predictors of outcome in acute encephalitis","volume":"81","author":"Thakur","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neulet.2022.136546_b0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12028-018-0536-6","article-title":"Clinical Characteristics and Prognosis of Severe Anti-N-methyl-d-aspartate Receptor Encephalitis Patients","volume":"29","author":"Zhang","year":"2018","journal-title":"Neurocrit. Care"},{"issue":"1","key":"10.1016\/j.neulet.2022.136546_b0040","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1212\/NXI.0000000000000514","article-title":"Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment","volume":"6","author":"Schubert","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.neulet.2022.136546_b0045","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1212\/WNL.0000000000006990","article-title":"Autoimmune encephalitis: A costly condition","volume":"92","author":"Cohen","year":"2019","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neulet.2022.136546_b0050","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1194\/jlr.M060970","article-title":"Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients","volume":"56","author":"Fellows","year":"2015","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.neulet.2022.136546_b0055","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp-2012-304740","article-title":"Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event","volume":"84","author":"Weinstock-Guttman","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"13","key":"10.1016\/j.neulet.2022.136546_b0060","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1177\/1352458514533162","article-title":"An adverse lipid profile is associated with disability and progression in disability, in people with MS","volume":"20","author":"Tettey","year":"2014","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.neulet.2022.136546_b0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2016-315037","article-title":"An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event","volume":"88","author":"Tettey","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2022.136546_b0070","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3389\/fneur.2019.01230","article-title":"Triglyceride Level Is an Independent Risk Factor in First-Attacked Neuromyelitis Optica Spectrum Disorders Patients","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neulet.2022.136546_b0075","doi-asserted-by":"crossref","first-page":"101981","DOI":"10.1016\/j.msard.2020.101981","article-title":"Low high-density lipoprotein cholesterol and high triglycerides lipid profile in neuromyelitis optica spectrum disorder: Associations with disease activity and disability","volume":"40","author":"Cho","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.neulet.2022.136546_b0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cca.2018.08.028","article-title":"Association of serum lipids with autoantibodies and inflammatory markers in rheumatoid arthritis patients","volume":"486","author":"Gan","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.neulet.2022.136546_b0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/joim.12743","article-title":"Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues","volume":"284","author":"Arias de la Rosa","year":"2018","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.neulet.2022.136546_b0090","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.neulet.2022.136546_b0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00296-015-3393-z","article-title":"Lipid profile among girls with systemic lupus erythematosus","volume":"37","author":"Machado","year":"2017","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.neulet.2022.136546_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2019.05.004","article-title":"Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE","volume":"205","author":"Ye","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.neulet.2022.136546_b0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12944-016-0229-0","article-title":"High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus","volume":"15","author":"Gaal","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.neulet.2022.136546_b0110","article-title":"Lipid profiles and their potential inflammatory effects in anti-N-methyl-D-aspartate receptor encephalitis","author":"Liu","year":"2020","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.neulet.2022.136546_b0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.neulet.2022.136546_b0120","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.STR.19.11.1448","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Bloch","year":"1988","journal-title":"Stroke"},{"issue":"4\u20135","key":"10.1016\/j.neulet.2022.136546_b0125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000485623","article-title":"Lipid Metabolism in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis","volume":"24","author":"Shu","year":"2017","journal-title":"NeuroImmunoModulation"},{"issue":"4","key":"10.1016\/j.neulet.2022.136546_b0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MOL.0b013e328355ca25","article-title":"HDL functionality","volume":"23","author":"Soran","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"issue":"12","key":"10.1016\/j.neulet.2022.136546_b0135","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1365-2362.2010.02361.x","article-title":"The versatility of HDL: a crucial anti-inflammatory regulator","volume":"40","author":"Saemann","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.neulet.2022.136546_b0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-nutr-071811-150709","article-title":"New roles of HDL in inflammation and hematopoiesis","volume":"32","author":"Zhu","year":"2012","journal-title":"Annu. Rev. Nutr."},{"issue":"1","key":"10.1016\/j.neulet.2022.136546_b0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3181\/0804-RM-136","article-title":"A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response","volume":"234","author":"Hoover-Plow","year":"2009","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"2","key":"10.1016\/j.neulet.2022.136546_b0150","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/all.14022","article-title":"Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naive allergic patients and allergen-challenged mice","volume":"75","author":"Roula","year":"2020","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.neulet.2022.136546_b0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-8-127","article-title":"Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis","volume":"8","author":"Weinstock-Guttman","year":"2011","journal-title":"J. Neuroinflamm."},{"issue":"1-2","key":"10.1016\/j.neulet.2022.136546_b0160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneuroim.2014.10.010","article-title":"A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis","volume":"277","author":"Meyers","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.neulet.2022.136546_b0165","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10067-018-4051-0","article-title":"Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus","volume":"37","author":"Atta","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.neulet.2022.136546_b0170","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1177\/0961203310373937","article-title":"Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort","volume":"19","author":"Ardoin","year":"2010","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.neulet.2022.136546_b0175","first-page":"221","article-title":"C-reactive protein (CRP) and autoimmune disease: facts and conjectures","volume":"11","author":"Szalai","year":"2004","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.neulet.2022.136546_b0180","doi-asserted-by":"crossref","first-page":"102374","DOI":"10.1016\/j.jaut.2019.102374","article-title":"Inflammatory markers in systemic lupus erythematosus","volume":"110","author":"Aringer","year":"2020","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.neulet.2022.136546_b0185","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neulet.2022.136546_b0190","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.braindev.2018.12.009","article-title":"Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective\/prospective cohort study","volume":"41","author":"Pruetarat","year":"2019","journal-title":"Brain Dev."},{"issue":"13","key":"10.1016\/j.neulet.2022.136546_b0195","doi-asserted-by":"crossref","first-page":"e19601","DOI":"10.1097\/MD.0000000000019601","article-title":"Predisposing factors and prognosis of status epilepticus in patients with autoimmune encephalitis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neulet.2022.136546_b0200","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3389\/fimmu.2019.01286","article-title":"Analysis of Clinical Characteristics and Poor Prognostic Predictors in Patients With an Initial Diagnosis of Autoimmune Encephalitis","volume":"10","author":"Qiu","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394022001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394022001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:42:07Z","timestamp":1759624927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394022001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"alternative-id":["S0304394022001033"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2022.136546","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low high-density lipoprotein cholesterol and apolipoprotein A-I levels are associated with poor outcome and relapse in autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2022.136546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"136546"}}